Medical Device News Magazine

Trudell Medical Group Makes a Strategic Investment in Xenocor

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Xenocor Inc. today announced a strategic investment by Barvest Ventures Inc., a member company of the Trudell Medical Group, which is an innovator and global leader in respiratory care and medical device development.

Xenocor notes this investment will enable Xenocor to ramp up production and respond to growing demand for the Xenoscope™ — an FDA-approved, single-use, fog-free, portable, high-definition (HD) laparoscopic imaging system.

In addition, George Baran, Chair of the Trudell Medical Group will join the Xenocor board bringing years of market wisdom and insight in the areas of product development, production and global market distribution. Northgate Technologies Inc., a member company of Trudell Medical Group that designs and manufactures urology and minimally invasive surgical equipment, will be working closely with Xenocor to bring additional synergies to the relationship.

“Innovation has been critical for delivering solutions that improve quality of life and create positive economic outcomes. This has been our mission since our inception in 1922,” said George Baran, Chairman of the Trudell Medical Group. “We feel our investment in Xenocor is a continuation of this tradition and see every reason for the Xenoscope to be successfully introduced into many markets around the world.”

The Xenoscope

The Xenoscope offers both clinical and financial advantages that positively impact surgeons, staff, healthcare facilities and patients.  The technological innovations provide vastly improved image quality (HD and fog-free), eliminate cross-contamination, reduce arc patient burn injuries, minimize technical complications and operation room downtimes. The compact, portable design is a single cord plug-and-play unit, which makes it possible for easy integration and usage in multiple locations.  There are no large capital expenditures or expensive long-term maintenance contracts so the Xenoscope is readily accessible to markets of varying size.

“Not only is Trudell Medical Group a global leader in its product categories, but they also manufacture adjunct products that compliment our current offerings.  This strategic investment alliance is a win-win partnership, which leaves the door open to additional innovation,” said Evan Kelso, CEO of Xenocor. “We feel fortunate to have George Baran on the board and such a commanding ally as we move this product into broader availability.”   

Medical Device News Magazine
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”

HeartFlow Introduces Next Generation Interactive Plaque Analysis Platform to Assess Patient Risk in Suspected Coronary Artery Disease

The HeartFlow Plaque Analysis uses proprietary algorithms to analyze coronary CT angiogram (CCTA) scans, creating a personalized 3D model that quantifies and characterizes plaque volume in the coronary arteries, aiding risk assessment of coronary artery disease. The technology was introduced at the Society of Cardiovascular Computed Tomography (SCCT) Annual Scientific Meeting in Washington, D.C.